GLAI — what changed in the latest 10-Q
A section-by-section comparison of GLAI's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-13 vs the prior 10-Q · 2026-06-03
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +28 | −14 | ~12 | 27 |
| Controls & procedures | Text added/removed | 0 | 0 | ~4 | 0 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | Text added/removed | 0 | 0 | ~1 | 0 |
| Other information | Text added/removed | +2 | −2 | 0 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Market risk (Item 3)
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-13
Cost of revenues (exclusive of amortization shown separately below) 33,278 41,703 (8,425) (20)%
Gross margin (exclusive of amortization shown separately below) 82,446 42,625 39,821 93%
Amortization of Capitalized research and development costs 342,910 - 342,910 100%
For the three months ended June 30, 2026, the Company generated revenues of $115,724, compared to $84,328 for the three months ended June 30, 2025, representing an increase of 37%. This increase was primarily due to an increase in revenues from software license sales and related services in 2026.
Operating expenses increased to $891,409 for the three months ended June 30, 2026, from $520,864 for the three months ended June 30, 2025, a 71% increase. The primary reason for the increase in operating expenses was the commencement of the amortization of capitalized research and development costs …
Text removed vs the prior filing · source: 10-Q · 2026-06-03
Revenues: The Company generated revenues of $44,747 for the three months ended March 31, 2026, compared to $35,704 for the three months ended March 31, 2025, representing an increase of 25.3%. This increase was primarily due to an increase in revenues from software license sales and related services…
Operating Expenses: Operating expenses increased to $839,733 for the three months ended March 31, 2026, from $744,855 for the three months ended March 31, 2025, representing a 12.7% increase. The primary reasons for the increase in operating expenses were increases in cost of revenues, amortization …
Amortization of Capitalized Research and Development Costs: Amortization of capitalized research and development costs were $305,413 for the three months ended March 31, 2026, compared to $0 for the three months ended March 31, 2025. The Company capitalized all research and development costs in 2025…
General and Administrative Expenses: General and administrative expenses were $193,773 for the three months ended March 31, 2026, compared to $112,387 for the three months ended March 31, 2025. The increase in general and administrative expenses of $81,368, or 72.4%, was primarily due to costs incur…
Research and Development Expenses: Research and development expenses were $47,822 for the three months ended March 31, 2026, compared to $0 for the three months ended March 31, 2025. The Company capitalized all research and development costs in 2025 and began expensing research and development costs…
Other information
Text added vs the prior filing · source: 10-Q · 2026-08-13
(b) There have been no material changes to the procedures by which security holders may recommend nominees to the Company’s Board of Directors since the Company last provided disclosure in response to the requirements of Item 407(c)(3) of Regulation S-K.
(c) During the registrant’s last fiscal quarter, no director or officer adopted or terminated: (i) any contract, instruction or written plan for the purchase or sale of securities of the registrant intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (a “Rule 10b5-1 trading arran…
Text removed vs the prior filing · source: 10-Q · 2026-06-03
Certain statements in this Quarterly Report on Form 10-Q contain or may contain forward-looking statements that are subject to known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any future results, perf…
When used in this Quarterly Report on Form 10-Q, the terms “Global AI”, the “Company”, “we,” “our,” and “us” refers to Global AI, Inc.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice